Advances in the signal transduction of ceramide and related sphingolipids

Critical Reviews in Clinical Laboratory Sciences

Volumn 36, Issue 6, 1999, Pages 511-573

  Gele, Liu ^a   Kleine, Leonard ^a   Hébert, Richard L ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Ceramide; Signal transduction; Sphingolipids

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CERAMIDE; NITRIC OXIDE SYNTHASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; RETINOBLASTOMA PROTEIN; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE ACYLTRANSFERASE; TRANSCRIPTION FACTOR;

APOPTOSIS; CALCIUM HOMEOSTASIS; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; ENZYME ACTIVATION; HUMAN; INFLAMMATION; LIPID METABOLISM; METABOLITE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0033373573     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408369991239240     Document Type: Review

References (423)

1. 1. Merrill AH Jr., Schmelz EM, Dillehay DL, et al., Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharm 1997; 142: 208-25.
2. 2. Olaisson H, Mardh S Arvidson G. Phospholipid organization in H,K-ATPase-containing membranes from pig gastric mucosa. J Biol Chem 1985; 260: 11262-7.
3. 3. Rawyler A, van der Schaft PH, Roelofsen B, et al. Phospholipid localization in the plasma membrane of Friend erythroleukemic cells and mouse erythrocytes. Biochemistry 1985; 24: 1777-83.
4. 4. Bartolf M, Franson RC. Characterization and localization of neutral sphingomyelinase in bovine adrenal medulla. J Lipid Res 1986; 27: 57-63.
5. 5. Hise MK, Mantulin WW Weinman EJ. Fatty acyl chain composition in the determination of renal membrane order. J Clin Invest 1986; 77: 768-73.
6. 6. Kolesnick RN, Clegg S. 1,2-Diacylglycerols, but not phorbol esters, activate a potential inhibitory pathway for protein kinase C in GH3 pituitary cells. Evidence for involvement of a sphingomyelinase. J Biol Chem 1988; 263: 6534-7.
7. 7. Mathias S, Dressler KA Kolesnick RN. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1991; 88: 10009-13.
8. 8. Dobrowsky RT, Hannun YA. Ceramide stimulates a cytosolic protein phosphatase. J Biol Chem 1992; 267: 5048-51.
9. 9. Merrill AH Jr, Lingrell S, Wang E, et al. Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion. J Biol Chem 1995; 270:13834-41.
10. 10. Ballou LR, Laulederkind SJ, Rosloniec EF, et al. Ceramide signalling and the immune response. Biochim Biophys Acta 1996; 1301: 273-87.
11. 11. Brindley DN, Abousalham A, Kikuchi Y, et al. "Cross talk" between the bioactive glycerolipids and sphingolipids in signal transduction. Biochem Cell Biol 1996; 74: 469-76.
12. 12. Paumen MB, Ishida Y, Muramatsu M, et al. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem 1997; 272: 3324-9.
13. 13. Kolesnick RN, Krönke M. Regulation of ceramide production and apoptosis. Annu Rev Physiol 1998; 60: 643-65.
14. 14. Hirschberg K, Rodger J Futerman AH. The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver. Biochem J 1993; 290: 751-7.
15. 15. Ridgway ND. 25-Hydroxycholesterol stimulates sphingomyelin synthesis in Chinese hamster ovary cells. J Lipid Res 1995; 36: 1345-58.
16. 16. Kok JW, Nikolova-Karakashian M, Klappe K, et al. Dihydroceramide biology. Structure-specific metabolism and intracellular localization. J Biol Chem 1997; 272: 21128-36.
17. 17. Merrill AH, Liotta DC Riley RE. Bioactive properties of sphingosine and structurally related compounds. In: Bell RM et al. ed. Handbook of lipid research V and lipid second messenger. p. 205-237. New York: Plenum Press, 1996.
18. 18. Heape AM, Boiron F, Bessoule JJ, et al. Peripheral nerve sphingomyelin and cerebroside are both formed via two metabolically and kinetically distinct pathways in vivo. Eur J Biochem 1994; 226: 491-504.
19. 19. Quinn P, Allan D. Two separate pools of sphingomyelin in BHK cells. Biochim Biophys Acta 1992; 1124: 95-100.
20. 20. Kallen KJ, Quinn P Allan D. Monensin inhibits synthesis of plasma membrane sphingomyelin by blocking transport of ceramide through the Golgi: evidence for two sites of sphingomyelin synthesis in BHK cells. Biochim Biophys Acta 1993; 1166: 305-8.
21. 21. Borchardt RA, Lee WT, Kalen A, et al. Growth-dependent regulation of cellular ceramides in human T-cells. Biochim Biophys Acta 1994; 1212: 327-36.
22. 22. Fitzgerald V, Blank ML Snyder F. Molecular species of sphingomyelin in sphingomyelinase-sensitive and sphingomyelinase-resistant pools of HL-60 cells. Lipids 1995; 30: 805-9.
23. 23. Kwon G, Bohrer A, Han X, et al. Characterization of the sphingomyelin content of isolated pancreatic islets. Evaluation of the role of sphingomyelin hydrolysis in the action of interleukin-1 to induce islet overproduction of nitric oxide. Biochim Biophys Acta 1996; 1300: 63-72.
24. 24. Peña LA, Fuks Z Kolesnick R. Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 1997; 53: 615-21.
25. 25. Taga S, Carlier K, Mishal Z, et al. Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells. Blood 1997; 90: 2757-67.
26. 26. Kolesnick R. 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res 1998; 58: 2260-4.
27. 27. Meacci E, Vasta V, Farnararo M, et al. Bradykinin increases ceramide and sphingosine content in human fibroblasts: possible involvement of glycosphingolipids. Biochem Biophys Res Commun 1996; 221: 1-7.
28. 28. Michel C, van Echten-Deckert G, Rother J, et al. Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J Biol Chem 1997; 272: 22432-7.
29. 29. Ghosh S, Strum JC Bell RM. Lipid biochemistry: function of glycerolipids and sphingolipids in cellular signaling. FASEB 1997; 11: 45-50.
30. 30. Liu B, Obeid LM Hannun YA. Sphingomyelinases in cell regulation. Semin Cell Dev Biol 1997; 311-22.
31. 31. Liu B, Andrieu-Abadie N, Levade T, et al. Hannun YA. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 1998; 273: 11313-20.
32. 32. Cifone MG, Roncaioli P, De Maria R, et al. Testi R. Multiple pathways originate at the Fas/ APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J 1995; 14: 5859-68.
33. 33. Schütze S, Machleidt T Kronke M. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leuk Biol 1994; 56: 533-41.
34. 2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J Biol Chem 1997; 272: 17196-203.
35. 2 activities against mixed lipid monolayers by their lipid intermediates and glycosphingolipids. Mol Membr Biol 1997; 14:25-9.
36. 36. Schissel SL, Tweedie-Hardman J, Rapp JH, et al. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest 1996; 98: 1455-64.
37. 37. Zhang P, Liu B, Jenkins GM, et al. Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. J Biol Chem 1997; 272: 9609-12.
38. 38. Chen J, Nikolova-Karakashian M, Merrill AH Jr, et al. Regulation of cytochrome P450 2C11 (CYP2C11 ) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes. J Biol Chem 1995; 270: 25233-8.
39. 39. Dobrowsky RT, Werner MH, Castellino AM, et al. Hannun YA. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994; 265: 1596-9.
40. 40. Yanaga F, Watson SP. Ceramide does not mediate the effect of tumour necrosis factor alpha on Superoxide generation in human neutrophils. Biochem J 1994; 298: 733-8.
41. 41. Simon CG Jr, Chatterjee S Gear AR. Sphingomyelinase activity in human platelets. Thromb Res 1998; 90: 155-61.
42. 42. Schissel SL, Keesler GA, Schuchman EH, et al. The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem 1998; 273: 18250-9.
43. 43. Field FJ, Chen H, Born E, et al. Release of ceramide after membrane sphingomyelin hydrolysis decreases the basolateral secretion of triacylglycerol and apolipoprotein B in cultured human intestinal cells. J Clin Invest 1993; 92: 2609-19.
44. 44. Raines MA, Kolesnick RN Golde DW. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J Biol Chem 1993; 268: 14572-5.
45. 45. Olivera A, Romanowski A, Rani CS, et al. Differential effects of Sphingomyelinase and cell-permeable ceramide analogs on proliferation of Swiss 3T3 fibroblasts. Biochim Biophys Acta 1997; 1348:311-23.
46. 46. Higuchi M, Singh S, Jaffrezou JP, et al. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation. J Immunol 1996; 157: 297-304.
47. 47. Lee JY, Leonhardt LG Obeid LM. Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M. Biochem J 1998; 334: 457-61.
48. 48. Xu J, Yeh CH, Chen S, et al. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem 1998; 273: 16521-6.
49. 49. Ohanian J, Liu G, Ohanian V, et al. Lipid second messengers derived from glycerolipids and sphingolipids, and their role in smooth muscle function. Acta Physiol Scand 1998; 164: 533-548.
50. 50. Luberto C, Hannun YA. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J Biol Chem 1998; 273: 14550-9.
51. 51. Schütze S, Wiegmann K, Machleidt T, et al. TNF-induced activation of NF-kappa B. Immunobiology 1995; 193: 193-203.
52. 52. Jabbar SA, Hoffbrand AV Wickremasinghe RG. Defects in signal transduction pathways in chronic B lymphocytic leukemia cells. Leuk Lymph 1995; 18: 163-70.
53. 53. Yada Y, Higuchi K Imokawa G. Purification and biochemical characterization of membrane-bound epidermal ceramidases from guinea pig skin. J Biol Chem 1995; 270: 12677-84.
54. 54. Boiron-Sargueil F, Heape A, Garbay B, et al. Cerebroside formation in the peripheral nervous system of normal and Trembler mice. Neurosci Lett 1995; 186: 21-4.
55. 55. Cifone MG, De Maria R, Roncaioli P, et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 1994; 180: 1547-52.
56. 56. Sjoholm A. Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin-1 beta. FEBS Lett 1995; 367: 283-6.
57. 57. Kanety H, Hemi R, Papa MZ, et al. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 1996; 271: 9895-7.
58. 58. Brogi A, Strazza M, Melli M, et al. Induction of intracellular ceramide by interleukin-1 beta in oligodendrocytes. J Cell Biochem 1997; 66: 532-41.
59. 59. Komori H, Ito M. Conversion of short-chain ceramides to short-chain ceramide GM3 in B16 melanoma cells. FEBS Lett 1995; 374: 299-302.
60. 60. Bielawska A, Greenberg MS, Perry D, et al. (1S,2R)-D-erythro-2-(N-myristoylamino)-I-phenyl-1-propanol as an inhibitor of ceramidase. J Biol Chem 1996; 271: 12646-54.
61. 61. Wiesner DA, Dawson G. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J Neurochem 1996; 66: 1418-25.
62. 62. Okino N, Tani M, Imayama S, et al. Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa. J Biol Chem 1998; 273: 14368-73.
63. 63. Mathias S, Peña LA Kolesnick RN. Signal transduction of stress via ceramide. Biochem J 1998; 335: 465-80.
64. 64. Shimeno H, Soeda S, Sakamoto M, et al. Partial purification and characterization of sphingosine N-acyltransferase(ceramide synthase) from bovine liver mitochondrion-rich fraction. Lipids 1998; 33: 601-5.
65. 65. Tsunoda M, Sharma RP Riley RT. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice. J Biochem Mol Toxicol 1998; 12: 281-9.
66. 66. Humpf HU, Schmelz EM, Meredith FL, et al. Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor. J Biol Chem 1998; 273: 19060-4.
67. 67. Ueda N, Kaushal GP, Hong X, et al. Role of enhanced ceramide generation in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells. Kidney Int 1998; 54: 399-406.
68. 68. Lochhead KM, Zager RA. Fluorinated anesthetic exposure "activates" the renal cortical sphingomyelinase cascade. Kidney Int 1998; 54: 373-81.
69. 69. Yokoyama K, Nojiri H, Suzuki M, et al. Clear differences in ceramide metabolism between glycosphingolipids and sphingomyelin in a human promyelocytic leukemia cell line HL-60 stimulated by a differentiation inducer. FEBS Lett 1995; 368: 477-80.
70. 70. Shinghal R, Scheller RH Bajjalieh SM. Ceramide 1-phosphate phosphatase activity in brain. J Neurochem 1993; 61: 2279-85.
71. 71. Mathias S, Younes A, Kan CC, et al. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 1993; 259: 519-22.
72. 72. Haimovitz-Friedman A, Kan CC, Ehleiter D, et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994; 180: 525-35.
73. 73. Chmura SJ, Mauceri HJ, Advani S, et al. Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation. Cancer Res 1997; 57: 4340-7.
74. 74. Strum JC, Small GW, Pauig SB, et al. 1-beta-D-Arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem 1994; 269: 15493-7.
75. 75. Liu G, Kleine L, Nasrallah R, et al. Bradykinin inhibits ceramide production and activates phospholipase D in rabbit RCCD cells. Am J Phys 1999; 276: F589-598.
76. 76. Gomez-Munoz A, Waggoner DW, O'Brien L, et al. Interaction of ceramides, sphingosine, and sphingosine 1-phosphate in regulating DNA synthesis and phospholipase D activity. J Biol Chem 1995; 270: 26318-25.
77. 77. Ji L, Zhang G Hirabayashi Y. Inhibition of tumor necrosis factor alpha-and ceramide-induced internucleosomal DNA fragmentation by herbimycin A in U937 cells. Biochem Biophys Res Commun 1995; 212: 640-7.
78. 78. Viani P, Zini I, Cervato G, et al. Effect of endothelin-1 induced ischemia on peroxidative damage and membrane properties in rat striatum synaptosomes. Neurochem Res 1995; 20: 689-95.
79. 2. Circ Res 1996; 79: 271-6.
80. 80. Catalan RE, Aragones MD Martinez AM, et al. Involvement of sphingolipids in the endothelin-1 signal transduction mechanism in rat brain. Neurosci Lett 1996; 220: 121-4.
81. 3 analogue, calcipotriol, induces sphingomyelin hydrolysis in human keratinocytes. FEBS Lett 1996; 378: 88-92.
82. 82. Linardic CM, Jayadev S Hannun YA. Activation of the sphingomyelin cycle by brefeldin A: effects of brefeldin A on differentiation and implications for a role for ceramide in regulation of protein trafficking. Cell Growth Differ 1996; 7: 765-74.
83. 83. Hedlund M, Svensson M, Nilsson A, et al. Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 1996; 183: 1037-44.
84. 84. Clejan S, Dotson RS, Wolf EW, et al. Morphological differentiation of N1E-115 neuroblastoma cells by dimethyl sulfoxide activation of lipid second messengers. Exp Cell Res 1996; 224: 16-27.
85. 85. Sillence DJ, Allan D. Evidence against an early signalling role for ceramide in Fas-mediated apoptosis. Biochem J 1997; 324: 29-32.
86. 86. Kinscherf R, Claus R, Deigner HP, et al. Modified low density lipoprotein delivers substrate for ceramide formation and stimulates the sphingomyelin-ceramide pathway in human macrophages. FEBS Lett 1997; 405: 55-9.
87. 87. Wiesner DA, Kilkus JP, Gottschalk AR, et al. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL. J Biol Chem 1997; 272: 9868-76.
88. 88. Sbrissa D, Yamada H, Hajra A, et al. Bombesin-stimulated ceramide production and MAP kinase activation in rabbit rectosigmoid smooth muscle cells. Am J Phys 1997; 272: G1615-25.
89. 89. Visnjic D, Batinic D Banfic H. Arachidonic acid mediates interferon-gamma-induced sphingomyelin hydrolysis and monocytic marker expression in HL-60 cell line. Blood 1997; 89: 81-91.
90. 90. Brenner B, Grassme HU, Muller C, et al. L-selectin stimulates the neutral sphingomyelinase and induces release of ceramide. Exp Cell Res 1998; 243: 123-8.
91. 91. Cabot MC, Han TY Giuliano AE. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation. FEBS Lett 1998; 431: 185-8.
92. 92. Separovic D, Mann KJ Oleinick NL. Association of ceramide accumulation with photodynamic treatment-induced cell death. Photochem Photobiol 1998; 68: 101-9.
93. 93. Gamen S, Hanson DA, Kaspar A, et al. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol 1998; 161: 1758-64.
94. 94. Suy S, Mitchell JB, Ehleiter D, et al. Nitroxides tempol and tempo induce divergent signal transduction pathways in MDA-MB 231 breast cancer cells. J Biol Chem 1998; 273: 17871-8.
95. 95. Galve-Roperh I, Sanchez C, Segui B, et al. Evidence for the lack of involvement of sphingomyelin hydrolysis in the tumor necrosis factor-induced secretion of nerve growth factor in primary astrocyte cultures. J Neurochem 1998; 71: 498-505.
96. 96. Gerritsen ME, Shen CP Perry CA. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha. Am J Pathol 1998; 152: 505-12.
97. 97. Allan-Yorke J, Record M, de Preval C, et al. Distinct pathways for tumor necrosis factor alpha and ceramides in human cytomegalovirus infection. J Virol 1998; 72: 2316-22.
98. 98. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, et al. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996; 383: 716-9.
99. 99. Haddad EB, Rousell J, Lindsay MA, et al. Synergy between tumor necrosis factor alpha and interleukin 1beta in inducing transcriptional down-regulation of muscarinic M2 receptor gene expression. Involvement of protein kinase A and ceramide pathways. J Biol Chem 1996; 271: 32586-92.
100. 100. Wiegmann K, Schütze S, Machleidt T, et al. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 1994; 78: 1005-15.
101. 101. Brenner B, Koppenhoefer U, Weinstock C, et al. Fas-or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J Biol Chem 1997; 272: 22173-81.
102. 102. Bilderback TR, Grigsby RJ Dobrowsky RT. Association of p75(NTR) with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae. J Biol Chem 1997; 272: 10922-7.
103. 103. Monney L, Olivier R, Otter I, et al. Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis. Eur J Biochem 1998; 251: 295-303.
104. 104. Tollefson AE, Hermiston TW, Lichtenstein DL, et al. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 1998; 392: 726-30.
105. 105. Anderson RG, Kamen BA, Rothberg KG, et al. Potocytosis: sequestration and transport of small molecules by caveolae. Science 1992; 255: 410-1.
106. 106. Liu P, Anderson RG. Compartmentalized production of ceramide at the cell surface. J Biol Chem 1993; 90: 10909-13.
107. 108. Okamoto T, Schlegel A, Scherer PE, et al. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 1998; 273: 5419-22.
108. 109. Teixeira A, Chaverot N, Schroder C, et al. Requirement of caveolae microdomains in extracellular signal-regulated kinase and focal adhesion kinase activation induced by endothelin-1 in primary astrocytes. J Neurochem 1999; 72: 120-8.
109. 110. Lobie PE, Sadir R, Graichen R, et al. Caveolar internalization of growth hormone. Exp Cell Res 1999; 246: 47-55.
110. 111. Smart EJ, Ying YS Anderson RG. Hormonal regulation of caveolae internalization. J Cell Biol 1995; 131: 929-38.
111. 112. Goldkorn T, Dressler KA, Muindi J, et al. Ceramide stimulates epidermal growth factor receptor phosphoryla-tion in A431 human epidermoid carcinoma cells. Evidence that ceramide may mediate sphingosine action. J Biol Chem 1991; 266: 16092-7.
112. 113. Joseph CK, Byun HS, Bittman R, et al. Substrate recognition by ceramide-activated protein kinase. Evidence that kinase activity is proline-directed. J Biol Chem 1993; 268: 20002-6.
113. 114. Liu J, Mathias S, Yang Z, et al. Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase. J Biol Chem 1994; 269: 3047-52.
114. 115. Nickels JT, Broach JR. A ceramide-activated protein phosphatase mediates ceramide-induced G1 arrest of Saccharomyces cerevisiae. Gene Dev 1996; 10: 382-94.
115. 116. Wolff RA, Dobrowsky RT, Bielawska A, et al. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem 1994; 269: 19605-9.
116. 117. Reyes JG, Robayna IG, Delgado PS, et al. Galarreta CMR. c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells. J Biol Chem 1996; 271: 21375-80.
117. 118. Prinetti A, Bassi R, Riboni L, et al. Involvement of a ceramide activated protein phosphatase in the differentiation of neuroblastoma Neuro2a cells. FEBS Lett 1997; 414: 475-9.
118. 119. Fishbein JD, Dobrowsky RT, Bielawska A, et al. Ceramide-mediated growth inhibition and CAPP are conserved in Saccharomyces cerevisiae. J Biol Chem 1993; 268: 9255-61.
119. 120. Dobrowsky RT, Kamibayashi C, Mumby MC, et al. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 1993; 268: 15523-30.
120. 121. Wong K, Li XB, Hunchuk N. N-acetylsphingosine (C2-ceramide) inhibited neutrophil super-oxide formation and calcium influx. J Biol Chem 1995; 270: 3056-62.
121. 122. Begum N, Ragolia L Srinivasan M. Effect of tumor necrosis factor-alpha on insulin-stimulated mitogen-activated protein kinase cascade in cultured rat skeletal muscle cells. Eur J Biochem 1996; 238: 214-20.
122. 123. Galadari S, Kishikawa K, Kamibayashi C, et al. Purification and characterization of ceramide-activated protein phosphatases. Biochemistry 1998; 37: 11232-8.
123. 124. Campbell SL, Khosravi-Far R, Rossman KL, et al. Increasing complexity of Ras signaling. Oncogene 1998; 17: 1395-1413.
124. 125. Dhanasekaran N, Tsim ST, Dermott JM, et al. Regulation of cell proliferation by G proteins. Oncogene 1998; 17: 1383-94.
125. 126. Dhanasekaran N, Premkumar Reddy E. Signaling by dual specificity kinases. Oncogene 1998; 17: 1447-55.
126. 127. Modur V, Zimmerman GA, Prescott SM, et al. Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and independent mitogen-activated protein kinase cascades. J Biol Chem 1996; 271: 13094-102.
127. 128. Huwiler A, Brunner J, Hummel R, et al. Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci USA 1996; 93: 6959-63.
128. 129. Belka C, Wiegmann K, Adam D, et al. Tumor necrosis factor (TNF)-alpha activates c-raf-I kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO J 1995; 14: 1156-65.
129. 130. Gulbins E, Bissonnette R, Mahboubi A, et al. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 1995; 2: 341-51.
130. 131. Gulbins E, Coggeshall KM, Brenner B, et al. Fas-induced apoptosis is mediated by activation of a Ras and Rac protein-regulated signaling pathway. J Biol Chem 1996; 271: 26389-94.
131. 132. Sasaki T, Hazeki K, Hazeki O, et al. Permissive effect of ceramide on growth factor-induced cell proliferation. Biochem J 1995; 311: 829-34.
132. 133. Westwick JK, Bielawska AE, Dbaibo G, et al. Ceramide activates the stress-activated protein kinases. J Biol Chem 1995; 270: 22689-92.
133. 134. Suchard SJ, Mansfield PJ, Boxer LA, et al. Mitogen-activated protein kinase activation during IgG-dependent phagocytosis in human neutrophils: inhibition by ceramide. J Immunol 1997; 158: 4961-7.
134. 135. Yao B, Zhang Y, Delikat S, et al. Phosphorylation of Raf by ceramide-activated protein kinase. Nature 1995; 378: 307-10.
135. 136. Basu S, Bayoumy S, Zhang Y, et al. BAD enables ceramide to signal apoptosis via Ras and Raf-1. J Biol Chem 1998; 273: 30419-26.
136. 137. Zhang Y, Yao B, Delikat S, et al. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 1997; 89: 63-72.
137. 138. Westwick JK, Weitzel C, Minden A, et al. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J Biol Chem 1994; 269: 26396-401.
138. 139. Winston BW, Lange-Carter CA, Gardner AM, et al. Tumor necrosis factor alpha rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-1-independent fashion in mouse macrophages. Proc Natl Acad Sci USA 1995; 92: 1614-8.
139. 140. Gardner AM, Johnson GL. Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 1996; 271: 14560-6.
140. 141. Muller G, Storz P, Bourteele S, et al. Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling. EMBO J 1998; 17: 732-42.
141. 142. Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369: 156-60.
142. 143. Derijard B, Hibi M, Wu IH, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76(6): 1025-37.
143. 144. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biology 1997; 9: 180-6.
144. 145. Basu S, Kolesnick R. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene 1998; 17: 3277-85.
145. 146. Verheij M, Ruiter GA, Zerp SF, et al. The role of the stress-activated protein kinase (SAPK/ JNK) signaling pathway in radiation-induced apoptosis. Radiother Oncol 1998; 47: 225-32.
146. 147. Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380: 75-9.
147. 148. Coroneos E, Wang Y, Panuska JR, et al. Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem J 1996; 316: 13-7.
148. 149. Cuvillier O, Pirianov G, Kleuser B, et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996; 381: 800-3.
149. 150. Pyne S, Chapman J, Steele L, et al. Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle. Eur J Biochem 1996; 237: 819-26.
150. 151. Jayadev S, Liu B, Bielawska AE, et al. Role for ceramide in cell cycle arrest. J Biol Chem 1995; 270: 2047-52.
151. 152. Jarvis WD, Kolesnick RN, Fornari FA, et al. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 1994; 91: 73-7.
152. 153. Obeid LM, Linardic CM, Karolak LA, et al. Programmed cell death induced by ceramide. Science 1993; 259: 1769-71.
153. 154. Zhang P, Miller BS, Rosenzweig SA, et al. Activation of C-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J Neurosci Res 1996; 46: 114-21.
154. 155. Yamaguchi K, Shirakabe K, Shibuya H, et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 1995; 270: 2008-11.
155. 156. Reunanen N, Westermarck J, Hakkinen L, et al. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem 1998; 273: 5137-45.
156. 157. Scheid MP, Foltz IN, Young PR, et al. Ceramide and cyclic adenosine monophosphate (cAMP) induce cAMP response element binding protein phosphorylation via distinct signaling pathways while having opposite effects on myeloid cell survival. Blood 1999; 93: 217-25.
157. 158. Subbaramaiah K, Chung WJ, Dannenberg AJ. Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J Biol Chem 1998; 273: 32943-9.
158. 159. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-31.
159. 160. Toyoshima F, Moriguchi T Nishida E. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J Cell Biol 1997; 139: 1005-15.
160. 161. Ludwig S, Engel K, Hoffmeyer A, et al. 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol 1996; 16: 6687-97.
161. 162. Gutkind JS. Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene 1998; 17: 1331-42.
162. 163. Ragg SJ, Kaga S, Berg KA, et al. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937. J Immunol 1998; 161: 1390-8.
163. 164. Hayakawa M, Jayadev S, Tsujimoto M, et al. Role of ceramide in stimulation of the transcription of cytosolic phospholipase A2 and cyclooxygenase 2. Biochem Biophys Res Co 1996; 220: 681-6.
164. 165. Kirtikara K, Laulederkind SJ, Raghow R, et al. An accessory role for ceramide in interleukin-1beta induced prostaglandin synthesis. Mol Cell Biochem 1998; 181: 41-8.
165. 166. Hashizume T, Kageura T Sato T. Different effects of cell-permeable ceramide analogs on platelet activation. Biochem Mol Biol Int 1998; 44: 489-96.
166. 167. Sato T, Kageura T, Hashizume T, et al. Stimulation by ceramide of phospholipase A2 activation through a mechanism related to the phospholipase C-initiated signaling pathway in rabbit platelets. J Biochem 1999; 125: 96-102.
167. 168. Huang HW, Goldberg EM Zidovetzki R. Ceramide induces structural defects into phosphatidylcholine bilayers and activates phospholipase A2. Biochem Biophys Res Co 1996; 220: 834-8.
168. 169. Muller G, Ayoub M, Storz P, et al. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995; 14: 1961-9.
169. 170. Abe A, Shayman JA. Purification and characterization of 1-O-acylceramide synthase, a novel phospholipase A2 with transacylase activity. J Biol Chem 1998; 273: 8467-74.
170. 171. Abe A, Shayman JA Radin NS. A novel enzyme that catalyzes the esterification of N-acetylsphingosine. Metabolism of C2-ceramides. J Biol Chem 1996; 271: 14383-9.
171. 172. Gomez-Munoz A, Martin A, O'Brien L, et al. Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts. J Biol Chem 1994; 269: 8937-43.
172. 173. Yoshimura S, Sakai H, Ohguchi K, et al. Changes in the activity and mRNA levels of phospholipase D during ceramide-induced apoptosis in rat C6 glial cells. J Neurochem 1997; 69:713-20.
173. 174. Nakamura Y, Nakashima S, Ojio K, et al. Ceramide inhibits IgE-mediated activation of phospholipase D, but not of phospholipase C, in rat basophilic leukemia (RBL-2H3) cells. J Immunol 1996; 156: 256-62.
174. 175. Exton JH. New developments in phospholipase D. J Biol Chem 1997; 272: 15579-82.
175. 176. Lacal JC. Regulation of proliferation and apoptosis by Ras and Rho GTPases through specific phospholipid-dependent signaling. FEBS Lett 1997; 410: 73-7.
176. 177. del Peso L, Lucas L, Esteve P, et al. Activation of phospholipase D by growth factors and oncogenes in murine fibroblasts follow alternative but cross-talking pathways. Biochem J 1997; 322: 519-28.
177. 178. Martin A, Brown FD, Hodgkin MN, et al. Activation of phospholipase D and phosphatidylinositol 4-phosphate 5-kinase in HL60 membranes is mediated by endogenous Arf but not Rho. J Biol Chem 1996; 271: 17397-403.
178. 179. Heller RA, Kronke M. Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 1994; 126: 5-9.
179. 180. Nakamura T, Abe A, Balazovich KJ, et al. Ceramide regulates oxidant release in adherent human neutrophils. J Biol Chem 1994; 269: 18384-9.
180. 181. Younes A, Kahn DW, Besterman JM, et al. Ceramide is a competitive inhibitor of diacylglycerol kinase in vitro and in intact human leukemia (HL-60) cells. J Biol Chem 1992; 267: 842-7.
181. 182. Venable ME, Blobe GC Obeid LM. Identification of a defect in the phospholipase D/ diacylglycerol pathway in cellular senescence. J Biol Chem 1994; 269: 26040-4.
182. 183. Venable ME, Bielawska A Obeid LM. Ceramide inhibits phospholipase D in a cell-free system. J Biol Chem 1996; 271: 24800-5.
183. 184. Jones MJ, Murray AW. Evidence that ceramide selectively inhibits protein kinase C-alpha translocation and modulates bradykinin activation of phospholipase D. J Biol Chem 1995; 270: 5007-13.
184. 185. Abousalham A, Liossis C, O'Brien L, et al. Cell-permeable ceramides prevent the activation of phospholipase D by ADP-ribosylation factor and RhoA. J Biol Chem 1997; 272: 1069-75.
185. 186. Esteve P, del Peso L Lacal JC. Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis. Oncogene 1995; 11: 2657-65.
186. 187. Esteve P, Embade N, Perona R, et al. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway. Oncogene 1998; 17: 1855-69.
187. 188. van Helvoort A, van't Hof W, Ritsema T, et al. Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby canine kidney) cells. Evidence for the reverse action of a sphingomyelin synthase. J Biol Chem 1994; 269: 1763-9.
188. 189. Kolesnick RN, Paley AE. 1,2-Diacylglycerols and phorbol esters stimulate phosphatidylcholine metabolism in GH3 pituitary cells. Evidence for separate mechanisms of action. J Biol Chem 1987; 262: 9204-10.
189. 190. Schütze S, Potthoff K, Machleidt T, et al. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 1992; 71: 765-76.
190. 191. Lozano J, Berra E, Municio MM, et al. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J Biol Chem 1994; 269: 19200-2.
191. 192. Adam D, Ruff A, Strelow A, et al. Induction of stress-activated protein kinases/c-Jun N-terminal kinases by the p55 tumour necrosis factor receptor does not require sphingomyelinases. Biochem J 1998; 333: 343-50.
192. 193. Machleidt T, Wiegmann K, Henkel T, et al. Sphingomyelinase activates proteolytic I kappa B-alpha degradation in a cell-free system. J Biol Chem 1994; 269: 13760-5.
193. 194. Lee JY, Hannun YA Obeid LM. Ceramide inactivates cellular protein kinase C alpha. J Biol Chem 1996; 271: 13169-74.
194. 195. Tanabe F, Cui SH Ito M. Ceramide promotes calpain-mediated proteolysis of protein kinase C beta in murine polymorphonuclear leukocytes. Biochem Bioph Res Co 1998; 242: 129-33.
195. 196. Sawai H, Okazaki T, Takeda Y, et al. Ceramide-induced translocation of protein kinase C-delta and epsilon to the cytosol. Implications in apoptosis. J Biol Chem 1997; 272: 2452-8.
196. 197. Galve-Roperh I, Haro A Diaz-Laviada I. Ceramide-induced translocation of protein kinase C zeta in primary cultures of astrocytes. FEBS Lett 1997; 415: 271-4.
197. 198. Diaz-Meco MT, Dominguez I, Sanz L, et al. ζ PKC induces phosphorylation and inactivation of I kappa B-alpha in vitro. EMBO J 1994; 13: 2842-8.
198. 199. Kelly ML, Tang Y, Rosensweig N, et al. Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha. Blood 1998; 92: 416-24.
199. 200. Zegers MMP, Hoekstra D. Sphingolipid transport to the apical plasma membrane domain in human hepatoma cells is controlled by PKC and PKA activity: a correlation with cell polarity in HepG2 cells. J Cell Biol 1997; 138: 307-21.
200. 201. Pahan K, Sheikh FG, Khan M, et al. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem 1998; 273:2591-600.
201. 202. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12: 141-79.
202. 203. Hatanaka Y, Fujii J, Fukutomi T, et al. Reactive oxygen species enhances the induction of inducible nitric oxide synthase by Sphingomyelinase in RAW264.7 cells. Biochim Biophys Acta 1998; 1393: 203-10.
203. 204. Shimabukuro M, Zhou YT, Levi M, et al. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998; 95: 2498-502.
204. 205. Sciorati C, Rovere P, Ferrarini M, et al. Clementi E. Autocrine nitric oxide modulates CD95-induced apoptosis in gamma delta T lymphocytes. J Biol Chem 1997; 272: 23211-5.
205. 206. Hebestreit H, Dibbert B, Balatti I, et al. Disruption of fas receptor signaling by nitric oxide in eosinophils. J Exp Med 1998; 187: 415-25.
206. 207. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-30.
207. 208. Dbaibo GS, Pushkareva MY, Jayadev S, et al. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci USA 1995; 92: 1347-51.
208. 209. Venable ME, Lee JY, Smyth MJ, et al. Role of ceramide in cellular senescence. J Biol Chem 1995; 270: 30701-8.
209. 210. Zhang J, Alter N, Reed JC, et al. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc Natl Acad Sci USA 1996; 93: 5325-8.
210. 211. Spinedi A, Amendola A, Di Bartolomeo S, et al. Ceramide-induced apoptosis is mediated by caspase activation independently from retinoblastoma protein post-translational modification. Biochem Biophys Res Commun 1998; 243: 852-7.
211. 212. Bowen C, Spiegel S Gelmann EP. Radiation-induced apoptosis mediated by retinoblastoma protein. Cancer Res 1998; 58: 3275-81.
212. 213. McConkey DJ, Goodrich D, Bucana C, et al. The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells. Oncogene 1996; 13: 1693-700.
213. 214. Oliverio S, Amendola A, Di Sano F, et al. Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol Cell Biol 1997; 17: 6040-8.
214. 215. Sawai H, Okazaki T Domae N. Ceramide: a lipid mediator of apoptotic signal transduction. Nippon Rinsho-Japanese J Clin Med 1996; 54: 1803-8.
215. 216. Zhao Y, Nichols JE, Valdez R, et al. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Mol Endocrinol 1996; 10: 1350-7.
216. 217. Welsh N. Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem 1996; 271: 8307-12.
217. 218. Gupta S, Campbell D, Derijard B, et al. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995; 267: 389-93.
218. 219. Yang Z, Costanzo M, Golde DW, et al. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells. J Biol Chem 1993; 268: 20520-3.
219. 220. Dbaibo GS, Obeid LM Hannun YA. Tumor necrosis factor-alpha (TNF-α) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNFα from activation of nuclear factor-kappa B. J Biol Chem 1993; 268: 17762-6.
220. 221. Singh S, Aggarwal BB. Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-κB. J Biol Chem 1995; 270: 10631-9.
221. 222. Betts JC, Agranoff AB, Nabel GJ, et al. Dissociation of endogenous cellular ceramide from NF-κB activation. J Biol Chem 1994; 269: 8455-8.
222. 223. Johns LD, Sarr T Ranges GE. Inhibition of ceramide pathway does not affect ability of TNF-α to activate nuclear factor-kappa B. J Immunol 1994; 152: 5877-82.
223. 2-ceramide activates c-fos serum response element via Rac-dependent signalling pathway. Biochem J 1998; 330: 1009-14.
224. 225. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-65.
225. 226. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-56.
226. 227. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-8.
227. 228. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13: 151-3.
228. 229. Vandenabeele P, Declercq W, Vanhaesebroeck B, et al. Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 1995; 154: 2904-13.
229. 230. Aggarwal BB, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 1996; 7: 93-124.
230. 231. Tartaglia LA, Ayres TM, Wong GH, et al. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74: 845-53.
231. 232. Itoh N, Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 1993; 268: 10932-7.
232. 233. Hsu H, Xiong J Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995; 81: 495-504.
233. 234. Chinnaiyan AM, O'Rourke K, Tewari M, et al. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505-12.
234. 235. Boldin MP, Varfolomeev EE, Pancer Z, et al. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995; 270: 7795-8.
235. 236. Yeh WC, Pompa JL, McCurrach ME, et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998; 279: 1954-8.
236. 237. Varfolomeev EE, Boldin MP, Goncharov TM, et al. A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other. J Exp Med 1996; 183: 1271-5.
237. 238. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817-27.
238. 239. Fernandes-Alnemri T, Armstrong RC, Krebs J, et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 1996; 93: 7464-9.
239. 240. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci 1997; 22: 299-306.
240. 241. Nunez G, Benedict MA, Hu Y, et al. Caspases: the proteases of the apoptotic pathway. Oncogene 1998; 17: 3237-45.
241. 242. Boldin MP, Goncharov TM, Goltsev YV, et al. Involvement of MACH, a novel MORTI/ FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 1996; 85: 803-15.
242. 243. Medema JP, Scaffidi C, Kischkel FC, et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997; 16: 2794-804.
243. 244. Scaffidi C, Medema JP, Krammer PH, et al. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 1997; 272: 26953-8.
244. 245. Ahmad M, Srinivasula SM, Wang L, et al. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 1997; 57: 615-9.
245. 246. Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature 1997; 385: 86-9.
246. 247. Vincenz C, Dixit VM. Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95-and p55-mediated death signaling. J Biol Chem 1997; 272: 6578-83.
247. 248. Zhang J, Cado D, Chen A, et al. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998; 392: 296-300.
248. 249. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801-9.
249. 250. Fernandes-Alnemri T, Litwack G Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994; 269: 30761-4.
250. 251. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
251. 252. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, et al. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 1996; 93: 14486-91.
252. 253. Fernandes-Alnemri T, Takahashi A, Armstrong R, et al. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 1995; 55: 6045-52.
253. 254. Dbaibo GS, Perry DK, Gamard CJ, et al. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J Exp Med 1997; 185: 481-90.
254. 255. Zhou Q, Snipas S, Orth K, et al. Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J Biol Chem 1997; 272: 7797-800.
255. 256. Li P, Allen H, Banerjee S, et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995; 80: 401-11.
256. 257. Rothe M, Wong SC, Henzel WJ, et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 1994; 78: 681-92.
257. 258. Weiss T, Grell M, Siemienski K, et al. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J Immunol 1998; 161: 3136-42.
258. 259. Rothe M, Pan MG, Henzel WJ, et al. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995; 83: 1243-52.
259. 260. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998; 17: 3261-70.
260. 261. Arch RH, Gedrich RW Thompson CB. Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Gene Dev 1998; 12: 2821-30.
261. 262. Hsu H, Shu HB, Pan MG, et al. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84: 299-308.
262. 263. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-α-induced cell death. Science 1996; 274: 782-4.
263. 264. Van Antwerp DJ, Martin SJ, Kafri T, et al. Suppression of TNFα-induced apoptosis by NF-kappaB. Science 1996; 274: 787-9.
264. 265. Wang CY, Mayo MW Baldwin AS Jr. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996; 274: 784-7.
265. 266. Wu M, Lee H, Bellas RE, et al. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J 1996; 15: 4682-90.
266. 267. Lee SY, Reichlin A, Santana A, et al. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 1997; 7: 703-13.
267. 268. Yeh WC, Shahinian A, Speiser D, et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997; 7: 715-25.
268. 269. Shu HB, Takeuchi M Goeddel DV. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAPI are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 1996; 93: 13973-8.
269. 270. Song HY, Rothe M Goeddel DV. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc Natl Acad Sci USA 1996; 93: 6721-5.
270. 271. Cheng G, Baltimore D. TANK, a co-inducer with TRAF2 of TNF-and CD 40L-mediated NF-κB activation. Gene Dev 1996; 10: 963-73.
271. 272. Rothe M, Xiong J, Shu HB, et al. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc Natl Acad Sci USA 1996; 93: 8241-6.
272. 273. Liu ZG, Hsu H, Goeddel DV, et al. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996; 87: 565-76.
273. 274. Kelliher MA, Grimm S, Ishida Y, et al. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 1998; 8: 297-303.
274. 275. Natoli G, Costanzo A, Ianni A, et al. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 1997; 275: 200-3.
275. 276. Reinhard C, Shamoon B, Shyamala V, et al. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J 1997; 16: 1080-92.
276. 277. Nishitoh H, Saitoh M, Mochida Y, et al. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol Cell 1998; 2: 389-95.
277. 278. Johnson NL, Gardner AM, Diener KM, et al. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem 1996; 271: 3229-37.
278. 279. Yang DD, Kuan CY, Whitmarsh AJ, et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 1997; 389: 865-70.
279. 280. Sakata N, Patel HR, Terada N, et al. Gelfand EW. Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J Biol Chem 1995; 270: 30823-8.
280. 281. Westwick JK, Weitzel C, Leffert HL, et al. Activation of Jun kinase is an early event in hepatic regeneration. J Clin Invest 1995; 95: 803-10.
281. 282. Hsueh YP, Lai MZ. c-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes. J Biol Chem 1995; 270: 18094-8.
282. 283. Goillot E, Raingeaud J, Ranger A, et al. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 1997; 94: 3302-7.
283. 284. Hannun YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 1994; 269: 3125-8.
284. 285. Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 1994; 77: 325-8.
285. 286. Hannun YA, Obeid LM. Ceramide: an intracellular signal for apoptosis. TIBS 1995; 20: 74-7.
286. 287. Jarvis WD, Fornari FA, Traylor RS, et al. Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J Biol Chem 1996; 271: 8275-84.
287. 288. Harada-Shiba M, Kinoshita M, Kamido H, et al. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem 1998; 273: 9681-7.
288. 289. Amarante-Mendes GP, Naekyung Kim C, Liu L, et al. Bcr-Ab1 exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Blood 1998; 91: 1700-5.
289. 290. Yoshimura S, Banno Y, Nakashima S, et al. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation. J Biol Chem 1998; 273: 6921-7.
290. 291. Yen CLE, Mar MH Zeisel SH. Choline deficiency-induced apoptosis in PC12 cells is associated with diminished membrane phosphatidylcholine and sphingomyelin, accumulation of ceramide and diacylglycerol, and activation of a caspase. FASEB J 1999; 13: 135-142.
291. 292. Harvey KF, Harvey NL, Michael JM, et al. Caspase-mediated cleavage of the ubiquitin-protein ligase Nedd4 during apoptosis. J Biol Chem 1998; 273: 13524-30.
292. 293. Ham J, Babij C, Whitfield J, et al. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 1995; 14: 927-39.
293. 294. Ichijo H, Nishida E, Irie K, et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997; 275: 90-4.
294. 295. Sawai H, Okazaki T, Yamamoto H, et al. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem 1995; 270: 27326-31.
295. 296. Zanke BW, Boudreau K, Rubie E, et al. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol 1996; 6: 606-13.
296. 297. Santana P, Peña LA, Haimovitz-Friedman A, et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996; 86: 189-99.
297. 298. Schwandner R, Wiegmann K, Bernardo K, et al. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J Biol Chem 1998; 273: 5916-22.
298. 299. Chinnaiyan AM, Tepper CG, Seldin MF, et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996; 271: 4961-5.
299. 300. Watts JD, Gu M, Patterson SD, et al. On the complexities of ceramide changes in cells undergoing apoptosis: lack of evidence for a second messenger function in apoptotic induction. Cell Death Differ 1999; 6: 105-114.
300. 301. Karasavvas N, Zakeri Z. Relationships of apoptotic signaling mediated by ceramide and TNF-α in U937 cells. Cell Death Differ 1999; 6: 115-123.
301. 302. Scurlock B, Dawson G. Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: Role of ceramide in apoptosis. J Neurosci Res 1999; 55: 514-522.
302. 303. Smyth MJ, Perry DK, Zhang J, et al. prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem J 1996; 316: 25-8.
303. 304. Sweeney EA, Inokuchi J Igarashi Y. Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide. FEBS Lett 1998; 425: 61-5.
304. 305. Genestier L, Prigent AF, Paillot R, et al. Caspase-dependent ceramide production in Fas-and HLA class I-mediated peripheral T cell apoptosis. J Biol Chem 1998; 273: 5060-6.
305. 306. Pronk GJ, Ramer K, Amiri P, et al. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 1996; 271: 808-10.
306. 307. Bose R, Chen P, Loconti A, et al. Ceramide generation by the Reaper protein is not blocked by the caspase inhibitor, p35. J Biol Chem 1998; 273: 28852-9.
307. 308. Herr I, Wilhelm D, Bohler T, et al. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J 1997; 16: 6200-8.
308. 309. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, et al. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996; 383: 716-9.
309. 310. Frade JM, Rodriguez-Tebar A Barde YA. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996; 383: 166-8.
310. 311. Dobrowsky RT. Carter BD. Coupling of the p75 neurotrophin receptor to sphingolipid signaling. Ann NY Acad Sci 1998; 845: 32-45.
311. 312. Dobrowsky RT, Jenkins GM Hannun YA. Neurotrophins induce sphingomyelin hydrolysis. Modulation by co-expression of p75NTR with Trk receptors. J Biol Chem 1995; 270: 22135-42.
312. 313. Casaccia-Bonnefil P, Aibel L Chao MV. Central glial and neuronal populations display differential sensitivity to ceramide-dependent cell death. J Neurosci Res 1996; 43: 382-9.
313. 314. Brugg B, Michel PP, Agid Y, et al. Ceramide induces apoptosis in cultured mesencephalic neurons. J Neurochem 1996; 66: 733-9.
314. 315. Hartfield PJ, Mayne GC Murray AW. Ceramide induces apoptosis in PC12 cells. FEBS Lett 1997; 401: 148-52.
315. 316. Khursigara G, Orlinick JR Chao MV. Association of the p75 neurotrophin receptor with TRAF6. J Biol Chem 1999; 274: 2597-2600.
316. 2+-independent sphingomyelinase activities precede commitment to apoptosis and are not a consequence of caspase 3-like activity in Molt-4 cells in response to thymidylate synthase inhibition by GW1843. Blood 1998; 91: 4350-60.
317. 318. Bose R, Verheij M, Haimovitz-Friedman A, et al. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995; 82: 405-14.
318. 319. Boland MP, Foster SJ O'Neill LA. Daunorubicin activates NFκB and induces kappaB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells. J Biol Chem 1997; 272: 12952-60.
319. 320. Jaffrezou JP, Levade T, Bettaieb A, et al. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J 1996; 15: 2417-24.
320. 321. Durrieu F, Belloc F, Lacoste L, et al. Caspase activation is an early event in anthracycline-induced apoptosis and allows detection of apoptotic cells before they are ingested by phagocytes. Exp Cell Res 1998; 240: 165-75.
321. 322. Adam D, Wiegmann K, Adam-Klages S, et al. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J Biol Chem 1996; 271: 14617-22.
322. 323. Adam-Klages S, Adam D, Wiegmann K, et al. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neu-tral sphingomyelinase. Cell 1996; 86: 937-47.
323. 324. Tepper CG, Jayadev S, Liu B, et al. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 1995; 92: 8443-7.
324. 325. Chmura SJ, Nodzenski E, Weichselbaum RR, et al. Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res 1996; 56: 2711-4.
325. 326. Gottschalk AR, Quintans J. Apoptosis in B lymphocytes: the WEHI-231 perspective. Immunol Cell Biol 1995; 73: 8-16.
326. 327. Andrieu N, Salvayre R Levade T. Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor necrosis factor and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem J 1994; 303: 341-5.
327. 328. Kuno K, Sukegawa K, Ishikawa Y, et al. Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NFkB activation. Int Immunol 1994; 6: 1269-72.
328. 329. Shirakabe K, Yamaguchi K, Shibuya H, et al. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem 1997; 272: 8141-4.
329. 330. Hurwitz R, Ferlinz K Sandhoff K. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol Chem H-S 1994; 375: 447-50.
330. 331. Slowik MR, De Luca LG, Min W, et al. Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells. Circ Res 1996; 79: 736-47.
331. 332. Rizzo MT, Carlo-Stella C. Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino-terminal kinases in stromal cells. Blood 1996; 88: 3792-800.
332. 333. Butterfield L, Storey B, Maas L, et al. c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J Biol Chem 1997; 272: 101 10-6.
333. 334. Zumbansen M, Stoffel W. Tumor necrosis factor alpha activates NF-κB in acid sphingomyelinase-deficient mouse embryonic fibroblasts. J Biol Chem 1997; 272: 10904-9.
334. 335. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-12.
335. 336. Susin SA, Zamzami N, Larochette N, et al. A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: application to ceramide-induced apoptosis. Exp Cell Res 1997; 236: 397-403.
336. 337. Marzo I, Brenner C, Zamzami N, et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 1998; 187: 1261-71.
337. 338. Susin SA, Zamzami N, Castedo M, et al. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J Exp Med 1997; 186: 25-37.
338. 339. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-89.
339. 340. Zou H, Henzel WJ, Liu X, et al. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90: 405-13.
340. 341. Adachi S, Cross AR Babior BM. Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J Biol Chem 1997; 272: 21878-82.
341. 342. Hakem R, Hakem A, Duncan GS, et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998; 94: 339-52.
342. 343. Kuida K, Haydar TF, Kuan CY, et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94: 325-37.
343. 344. Vander Heiden MG, Chandel NS, Williamson EK, et al. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997; 91: 627-37.
344. 345. Rosse T, Olivier R, Monney L, et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 1998; 391: 496-9.
345. 346. Reed JC. Bcl-2 family proteins. Oncogene 1998; 17: 3225-36.
346. 347. Pan G, O'Rourke K Dixit VM. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem 1998; 273: 5841-5.
347. 348. Hu Y, Benedict MA, Wu D, et al. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 1998; 95: 4386-91.
348. 349. Wang HG, Rapp UR Reed JC. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996; 87: 629-38.
349. 350. Zha J, Harada H, Yang E, et al. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996; 87: 619-28.
350. 351. Kuwana T, Smith JJ, Muzio M, et al. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem 1998; 273: 16589-94.
351. 352. Luo X, Budihardjo I, Zou H, et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-90.
352. 353. Li H, Zhu H, Xu CJ, et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
353. 354. Bossy-Wetzel E, Newmeyer DD Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998; 17: 37-49.
354. 355. Garcia-Ruiz C, Colell A, Mari M, et al. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem 1997; 272: 11369-77.
355. 356. Arora AS, Jones BJ, Patel TC, et al. Ceramide induces hepatocyte cell death through disruption of mitochondrial function in the rat. Hepatology 1997; 25: 958-63.
356. 357. Pastorino JG, Simbula G, Yamamoto K, et al.The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 1996; 271: 29792-8.
357. 358. Kluck RM, Bossy-Wetzel E, Green DR, et al. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-6.
358. 359. Ghafourifar P, Klein SD, Schucht O, et al. Ceramide induces cytochrome c release from isolated mitochondria - importance of mitochondrial redox state. J Biol Chem 1999; 274: 6080-6084.
359. 360. Cecconi F, Alvarez-Bolado G, Meyer BI, et al. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 1998; 94: 727-37.
360. 361. El-Assaad W, El-Sabban M, Awaraji C, et al. Distinct sites of action of Bcl-2 and Bcl-xL in the ceramide pathway of apoptosis. Biochem J 1998; 336: 735-41.
361. 362. Quillet-Mary A, Jaffrezou JP, Mansat V, et al. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 1997; 272: 21388-95.
362. 363. Liu B, Hannun YA. Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J Biol Chem 1997; 272: 16281-7
363. 2 redox stress. Am J Resp Cell Mol Biol 1998; 19: 786-98.
364. 365. Ghosh TK, Bian J Gill DL. Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. J Biol Chem 1994; 269: 22628-35.
365. 366. Mattie M, Brooker G Spiegel S. Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. J Biol Chem 1994; 269: 3181-8.
366. 367. Zhang H, Desai NN, Olivera A, et al. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol 1991; 114: 155-67.
367. ++ from inositol trisphosphate-and phosphatidic acid-sensitive intracellular stores through a mechanism independent of inositol trisphosphate. J Biol Chem 1996; 271: 11148-55.
368. 369. Jacobs LS, Kester M. Sphingolipids as mediators of effects of platelet-derived growth factor in vascular smooth muscle cells. Am J Phys 1993; 265: C740-7.
369. 370. Wong K, Kwan-Yeung L. Sphingosine mobilizes intracellular calcium in human neutrophils. Cell Calcium 1993; 14: 493-505.
370. + depolarization in synaptosomes. J Neurochem 1993; 61: 443-50.
371. ++ channel conductance. Circ Res 1994; 75: 981-9.
372. 373. van Echten-Deckert G, Schick A, Heinemann T, et al. Phosphorylated cis-4-methylsphingosine mimics the mitogenic effect of sphingosine-1-phosphate in Swiss 3T3 fibroblasts. J Biol Chem 1998; 273: 23585-9.
373. 374. Webster RJ, Sabbadini RA, Dettbarn CA, et al. Sphingosine effects on the contractile behavior of skinned cardiac myocytes. J Mol Cell Cardiol 1994; 26: 1273-90.
374. 375. Tokura Y, Wakita H, Yagi H, et al. Th2 suppressor cells are more susceptible to sphingosine than Th1 cells in murine contact photosensitivity. Source J Invest Dermatol 1996; 107: 34-40.
375. 376. Mathes C, Fleig A Penner R. Calcium release-activated calcium current (ICRAC) is a direct target for sphingosine. J Biol Chem 1998; 273: 25020-30.
376. 377. Tornquist K, Pasternack M Kaila K. Sphingosine derivatives inhibit depolarization-evoked calcium entry in rat GH4C1 cells. Endocrinology 1995; 136: 4894-902.
377. 378. Sugiya H, Furuyama S. Sphingosine stimulates calcium mobilization in rat parotid acinar cells. FEBS Lett 1991; 286: 113-6.
378. 379. Chao CP, Laulederkind SJ Ballou LR. Sphingosine-mediated phosphatidylinositol metabolism and calcium mobilization. J Biol Chem 1994; 269: 5849-56.
379. 380. Postma FR, Jalink K, Hengeveld T, et al. Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO J 1996; 15: 2388-92.
380. 381. Yatomi Y, Ruan F, Hakomori S, et al. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995; 86: 193-202.
381. 382. Negishi T, Chik CL Ho AK. Ceramide selectively inhibits calcium-mediated potentiation of beta-adrenergic-stimulated cyclic nucleotide accumulation in rat pinealocytes. Biochem Biophys Res Commun 1998; 244: 57-61.
382. 383. Schreur KD, Liu S. Involvement of ceramide in inhibitory effect of IL-1 beta on L-type Ca++ current in7BSUP ad7ESUPult rat ventricular myocytes. Am J Phys 1997; 272: H2591-8.
383. 384. Furukawa K, Mattson MP. The transcription factor NF-κB mediates increases in calcium currents and decreases in NMDA-and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J Neurochem 1998; 70: 1876-86.
384. 6-ceramide maintains elevated cytosolic calcium levels in activated platelets. Thromb Res 1996; 81: 219-29.
385. 2-ceramide primes specifically for the superoxide anion production induced by N-formylmethionylleucyl phenylalanine (fMLP) in human neutrophils. Biochim Biophys Acta 1996; 1299: 259-66.
386. 387. Hannun YA, Loomis CR, Merrill AH Jr, et al. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 1986; 261: 12604-9.
387. 388. Hannun YA, Bell RM. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 1987; 235: 670-4.
388. 389. Hannun YA, Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 1989; 243: 500-7.
389. 390. Merrill AH Jr, Nimkar S, Menaldino D, et al. Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds. Biochemistry 1989; 28: 3138-45.
390. 391. Coroneos E, Martinez M, McKenna S, et al. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation. J Biol Chem 1995; 270: 23305-9.
391. 392. Schroeder JJ, Crane HM, Xia J, et al. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin BI. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. J Biol Chem 1994; 269: 3475-81.
392. 393. Hauser JM, Buehrer BM Bell RM. Role of ceramide in mitogenesis induced by exogenous sphingoid bases. J Biol Chem 1994; 269: 6803-9.
393. 394. Wakita H, Tokura Y, Yagi H, et al. Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is promoted by sphingosine. Arch Dermatol Res 1994; 286: 350-4.
394. 395. Alesenko AV, Pantaz EA, Pushkareva MIu, et al. [Change in the level of endogenous sphingosine in cell nuclei from regenerating rat liver]. Izmenenie urovnia endogennogo sfingozina v iadrakh kletok regeneriruiushchei pecheni krys. Biokhimiia 1993; 58: 461-70.
395. 396. Ella KM, Qi C, Dolan JW, et al. Characterization of a sphingomyelinase activity in Saccharomyces cerevisiae. Arch Biochem Biophys 1997; 340: 101-10.
396. 397. Yamada T, Okajima F, Ohwada S, et al. Growth inhibition of human pancreatic cancer cells by sphingosylphosphorylcholine and influence of culture conditions. Cell Mol Life Sci 1997; 53: 435-41.
397. 398. Hashizume T, Nakao M Sato T. Sphingosine enhances phosphatidylinositol 4-kinase activity in rabbit platelets. J Biochem 1996; 120: 61-5.
398. 399. Ohta H, Yatomi Y, Sweeney EA, et al. A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-alpha in human neutrophils. FEBS Lett 1994; 355: 267-70.
399. 400. Krown KA, Page MT, Nguyen C, et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996; 98: 2854-65.
400. 401. Alesenko AV, Boikov PIa, Drobot LB, et al. Filippova GN. [Change in the level of sphingosine in rat liver nuclei and cells during oncogene superexpression induced by cycloheximide]. Izmenenie urovnia sfingozina v iadrakh i kletkakh pecheni krys pri indutsirovannoi superekspressii onkogenov tsiklogeksimidom. Biokhimiia 1994; 59: 1076-87.
401. 402. Olivera A, Zhang H, Carlson RO, et al. Spiegel S. Stereospecificity of sphingosine-induced intracellular calcium mobilization and cellular proliferation. J Biol Chem 1994; 269: 17924-30.
402. 403. Megidish T, White T, Takio K, et al. The signal modulator protein 14-3-3 is a target of sphingosine-or N,N-dimethylsphingosine-dependent kinase in 3T3(A31) cells. Biochem Biophys Res Commun 1995; 216: 739-47.
403. 404. Megidish T, Cooper J, Zhang L, et al. A novel sphingosine-dependent protein kinase (SDK1) specifically phosphorylates certain isoforms of 14-3-3 protein. J Biol Chem 1998; 273: 21834-45.
404. 405. Wang F, Buckley NE, Olivera A, et al. Involvement of sphingolipids metabolites in cellular proliferation modulated by ganglioside GM1. Glycoconjugate J 1996; 13: 937-45.
405. 406. Kohama T, Olivera A, Edsall L, et al. Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 1998; 273: 23722-8.
406. 407. Cuvillier O, Rosenthal DS, Smulson ME, et al. Sphingosine 1 -phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas-and ceramide-mediated apoptosis in Jurkat T lymphocytes. J Biol Chem 1998; 273: 2910-6.
407. 3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase. Cancer Res 1998; 58: 1817-24.
408. 409. Ohta H, Sweeney EA, Masamune A, et al. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res 1995; 55: 691-7.
409. 410. Kishida E, Yano M, Kasahara M, et al. Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. Biochim Biophys Acta 1998; 1391: 401-8.
410. 411. Spiegel S, Cuvillier O, Edsall LC, et al. Sphingosine-1-phosphate in cell growth and cell death. Ann NY Acad Sci 1998; 845: 11-8.
411. 412. Edsall LC, Van Brocklyn JR, Cuvillier O, et al. N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry 1998; 37: 12892-8.
412. 413. Mandala SM, Thornton R, Tu Z, et al. Sphingoid base 1-phosphate phosphatase: a key regulator of sphingolipid metabolism and stress response. Proc Natl Acad Sci USA 1998; 95: 150-5.
413. 414. Yatomi Y, Yamamura S, Ruan F, et al. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. J Biol Chem 1997; 272: 5291-7.
414. 415. Yamamura S, Yatomi Y, Ruan F, et al. Sphingosine 1-phosphate regulates melanoma cell motility through a receptor-coupled extracellular action and in a pertussis toxin-insensitive manner. Biochemistry 1997; 36: 107519.
415. 416. van Koppen C, Meyer zu Heringdorf M, Laser KT, et al. Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine-1-phosphate. J Biol Chem 1996; 271: 2082-7.
416. 417. Igarashi Y. Sphingosine-1-phosphate as an intercellular signaling molecule. Ann NY Acad Sci 1998; 845: 19-31.
417. 418. Lee MJ, Van Brocklyn JR, Thangada S, et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998; 279: 1552-5.
418. 419. Gomez-Munoz A. Modulation of cell signalling by ceramides. Biochim Biophys Acta 1998; 1391: 92-109.
419. 420. Gomez-Munoz A, Frago LM, Alvarez L, et al. Stimulation of DNA synthesis by natural ceramide 1-phosphate. Biochem J 1997; 325: 435-40.
420. 421. Bettaieb A, Plo I, Mansat-De Mas V, et al. Daunorubicin-and mitoxantrone-triggered phosphatidylcholine hydrolysis: Implication in drug-induced ceramide generation and apoptosis. Mol Pharmacol 1999; 55: 118-125.
421. 422. Laurenz JC, Gunn JM, Jolly CA, et al. Alteration of glycerolipid and sphingolipid-derived second messenger kinetics in ras transformed 3T3 cells. Biochim Biophys Acta 1996; 1299: 146-54.
422. 2. Eur Biophys J 1998; 27: 361-6.
423. 424. Wang YM, Seibenhener ML, Vandenplas ML, et al. Atypical PKCζ is activated by ceramide, resulting in coactivation of NF-κB/JNK kinase and cell survival J Neurosci Res 1999; 55: 293-302.